Glucose metabolism in patients with subclinical Cushing’s syndrome

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Endocrine

• Publication date

  2012-03-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12020-012-9628-9PMID 22391939
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• an update on

  2014cited by this paper
• What is a randomised controlled trial?

  2013cited by this paper
• AME position statement on adrenal incidentaloma.

  2011cited by this paper
• Diagnosis and Treatment of Subclinical Hypercortisolism

  2011influential reference
• LXRβ is required for glucocorticoid-induced hyperglycemia and hepatosteatosis in mice.

  2011cited by this paper
• Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial

  2011cited by this paper
• The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause‐effect relationship?

  2011cited by this paper
• Diabetes in Cushing syndrome: basic and clinical aspects.

  2011cited by this paper
• Aberrant cortisol responses to physiological stimuli in patients presenting with bilateral adrenal incidentalomas

  2011cited by this paper
• Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects

  2010cited by this paper
• Is there value in routine screening for Cushing's syndrome in patients with diabetes?

  2010cited by this paper
• Screening for Subclinical Cushing's Syndrome in Type 2 Diabetes Mellitus: Low False-Positive Rates with Nocturnal Salivary Cortisol

  2010cited by this paper
• Pathophysiology of Diabetes Mellitus in Cushing’s Syndrome

  2010cited by this paper
• Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism.

  2010cited by this paper
• Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas.

  2010cited by this paper
• Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience

  2010cited by this paper
• An Endocrine Society Clinical Practice Guideline Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient:

  2010cited by this paper
• Approach to the patient with an adrenal incidentaloma.

  2010cited by this paper
• Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: a long-term follow-up study.

  2009cited by this paper
• Novel insights into glucocorticoid‐mediated diabetogenic effects: towards expansion of therapeutic options?

  2009cited by this paper
• American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: executive summary of recommendations.

  2009cited by this paper
• Hormonal activity of adrenal incidentalomas: results from a long‐term follow‐up study

  2009cited by this paper
• Surgical Versus Conservative Management for Subclinical Cushing Syndrome in Adrenal Incidentalomas: A Prospective Randomized Study

  2009cited by this paper
• The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas.

  2009cited by this paper
• Exploration and management of adrenal incidentalomas. French Society of Endocrinology Consensus.

  2008cited by this paper
• Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushing's syndrome.

  2008cited by this paper
• Subclinical hypercortisolism in hospitalized patients with type 2 diabetes mellitus.

  2008cited by this paper
• The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

  2008cited by this paper
• Cushing’s syndrome in a clinic population with diabetes

  2008influential reference
• Clinical practice. The incidentally discovered adrenal mass.

  2007cited by this paper
• The incidentally discovered adrenal mass

  2007cited by this paper
• Screening of Cushing's syndrome in adult patients with newly diagnosed diabetes mellitus

  2007cited by this paper
• Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism.

  2007cited by this paper
• "Subclinical Cushing's syndrome" is not subclinical: improvement after adrenalectomy in 9 patients.

  2007cited by this paper
• Glucocorticoid-induced osteoporosis: an update.

  2006cited by this paper
• Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications

  2006cited by this paper
• Evaluation of the Cardiovascular Risk in Patients with Subclinical Cushing Syndrome Before and After Surgery

  2006cited by this paper
• A Prospective, Randomized Study

  2006cited by this paper
• Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas

  2005cited by this paper
• Elevated late‐night salivary cortisol levels in elderly male type 2 diabetic veterans

  2005cited by this paper
• Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma.

  2005cited by this paper
• Subclinical Cushing's syndrome in adrenal incidentalomas.

  2005cited by this paper
• Subclinical Cushing's Syndrome

  2005cited by this paper
• Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients.

  2005cited by this paper
• Subclinical Cushing's syndrome in adrenal incidentalomas.

  2004cited by this paper
• 11β-hydroxysteroid dehydrogenases: changing glucocorticoid action

  2004cited by this paper
• Clinical implications

  2004cited by this paper
• The clinically inapparent adrenal mass: update in diagnosis and management.

  2004cited by this paper
• Prevalence of subclinical Cushing's syndrome in 70 patients with adrenal incidentaloma: clinical, biochemical and surgical outcomes.

  2003cited by this paper
• Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery.

  2003cited by this paper
• Management of the Clinically Inapparent Adrenal Mass (Incidentaloma)

  2003cited by this paper
• Occult Cushing's syndrome in type-2 diabetes.

  2003cited by this paper
• Adrenal incidentaloma: a new cause of the metabolic syndrome?

  2003cited by this paper
• Glucocorticoid receptor variants: clinical implications.

  2002cited by this paper
• Adrenal incidentaloma: a new cause of the metabolic syndrome?

  2002cited by this paper
• Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk.

  2002cited by this paper
• The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection

  2001cited by this paper
• [Detection of preclinical Cushing's syndrome in overweight type 2 diabetic patients].

  2001cited by this paper
• [Detection of preclinical Cushing's syndrome in overweight type 2 diabetic patients].

  2000cited by this paper
• A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology.

  2000cited by this paper
• Subclinical Cushing's syndrome.

  2000influential reference
• Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.

  2000cited by this paper
• A Survey on Adrenal Incidentaloma in Italy

  2000influential reference
• Glucocorticoids and insulin resistance: old hormones, new targets.

  1999cited by this paper
• Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance.

  1997cited by this paper
• Incidentally discovered adrenal masses.

  1997cited by this paper
• Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids.

  1997cited by this paper
• A long-term follow-up study

  1997influential reference
• Basic and Clinical Aspects

  1997cited by this paper
• Incidentalomas. A disease of modern technology.

  1997cited by this paper
• Pre‐clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients

  1996cited by this paper
• Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids.

  1996cited by this paper
• Basic and clinical aspects

  1996influential reference
• Adrenal incidentalomas: a manifestation of the metabolic syndrome?

  1996cited by this paper
• Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids.

  1994cited by this paper
• A-I-D-S: the new endocrine epidemic.

  1994cited by this paper
• Feast and famine: critical role of glucocorticoids with insulin in daily energy flow.

  1993cited by this paper
• The ovine corticotropin-releasing hormone-stimulation test in type I diabetic patients and controls: suggestion of mild chronic hypercortisolism.

  1993cited by this paper
• Diabetic neuropathy is associated with increased activity of the hypothalamic-pituitary-adrenal axis.

  1993cited by this paper
• Central glucocorticoid regulation of parasympathetic drive to pancreatic B-cells in the obese fa/fa rat.

  1991cited by this paper
• Incidentally discovered adrenal masses.

  1989cited by this paper
• Hypercortisolism in Diabetes Mellitus

  1987cited by this paper
• :A long term follow-up study

  1982cited by this paper

• Protective Role of Gallic Acid Against Corticosterone-Induced Hepatic Toxicity: Modulation of Oxidative Stress and Inflammatory Pathways in Wistar Rats

  2025cites this paper
• Adrenal Incidentaloma: From Silent Diagnosis to Clinical Challenge

  2025cites this paper
• Practical therapeutic approach in the management of diabetes mellitus secondary to Cushing’s syndrome, acromegaly and neuroendocrine tumours

  2023cites this paper
• Toward Systems-Level Metabolic Analysis in Endocrine Disorders and Cancer

  2023cites this paper
• Progress in Subclinical Cushing’s Syndrome

  2023cites this paper
• Development and Validation of Sensitive, Fast and Simple LC-MS/MS Method to Investigate the Association between Adrenocortical Steroidogenesis and the High Intensity Exercise in Elite Athletes

  2023cites this paper
• Frequently asked questions and answers (if any) in patients with adrenal incidentaloma

  2021cites this paper
• Characteristics of preoperative steroid profiles and glucose metabolism in patients with primary aldosteronism developing adrenal insufficiency after adrenalectomy

  2021cites this paper
• Epicardial Adipose Tissue: From Cell to Clinic

  2020cites this paper
• Cardiovascular and metabolic risk factors in patients with subclinical Cushing

  2020cites this paper
• Adrenal Secretome and Epicardial Adipose Tissue

  2020cites this paper
• Adrenal Incidentaloma

  2020cites this paper
• Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study

  2020cites this paper
• Adrenal incidentaloma: cardiovascular and metabolic effects of mild cortisol excess.

  2020cites this paper
• Modern Management of Mild Autonomous Cortisol Secretion

  2019cites this paper
• Diabètes secondaires

  2019cites this paper
• Abnormal glucose tolerance in a patient with pheochromocytoma and ACTH-independent subclinical Cushing’s syndrome involving the same adrenal gland

  2019cites this paper
• Regulation of growth hormone biosynthesis by Cdk5 regulatory subunit associated protein 1-like 1 (CDKAL1) in pituitary adenomas.

  2019influential citation
• Regulation of growth hormone biosynthesis by Cdk 5 regulatory subunit associated protein 1-like 1 ( CDKAL 1 ) in pituitary adenomas

  2019influential citation
• Predictability of hypoadrenalism occurrence and duration after adrenalectomy for ACTH-independent hypercortisolism

  2018cites this paper
• Metabolomics reveals new metabolic perturbations in children with type 1 diabetes

  2018cites this paper
• Cushing’s Syndrome

  2018cites this paper
• Cardiovascular mortality in patients with subclinical Cushing.

  2018cites this paper
• Autonomous hypercortisolism: definition and clinical implications.

  2018cites this paper
• Could Lipid Profile be Used as a Marker of Autonomous Cortisol Secretion in Patients with Adrenal Incidentalomas?

  2018cites this paper
• Evidence-Based Endocrine Surgery

  2018cites this paper
• Étude in vivo des interactions entre le système endocannabinoïde et l’axe corticotrope chez l’homme

  2017influential citation
• Cardiovascular events in patients with mild autonomous cortisol secretion: analysis with artificial neural networks.

  2017cites this paper
• Adrenal Mass: Insight Into Pathogenesis and a Common Link With Insulin Resistance

  2017cites this paper
• Is It Relevant to Screen Subclinical Cushing’s Syndrome in Patients With Type 2 Diabetes Mellitus?

  2017cites this paper
• Subclinical Hypercortisolism: How to Deal with It?

  2016cites this paper
• Prediction of Vertebral Fractures in Patients With Monolateral Adrenal Incidentalomas.

  2016cites this paper
• Adrenal incidentalomas: A guide to assessment, treatment and follow-up.

  2016cites this paper
• Subclinical Cushing’s syndrome in patients with bilateral compared to unilateral adrenal incidentalomas: a systematic review and meta-analysis

  2016cites this paper
• Adrenocortical tumors and insulin resistance: What is the first step?

  2016cites this paper
• Association of depression with pre-diabetes, undiagnosed diabetes, and previously diagnosed diabetes: a meta-analysis

  2016cites this paper
• Relevance and perspective concept of investigation of subclinical Cushing syndrome.

  2016cites this paper
• Adrenalectomy reduces the risk of vertebral fractures in patients with monolateral adrenal incidentalomas and subclinical hypercortisolism.

  2016cites this paper
• Metabolic comorbidities in Cushing's syndrome.

  2015cites this paper
• Biomarkers of physical activity and exercise.

  2015cites this paper
• Subclinical hypercortisolism: a state, a syndrome, or a disease?

  2015cites this paper
• Subclinical hypercortisolism in adrenal incidentaloma

  2015cites this paper
• Effects of group exercise on salivary biomarkers of mucosal immunity and hypothalamic-pituitary adrenal axis activation in older persons living in aged care facilities.

  2015cites this paper
• Adrenal gland volume, intra-abdominal and pericardial adipose tissue in major depressive disorder.

  2015cites this paper
• Glucose Metabolism in Primary Aldosteronism

  2015cites this paper
• The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications

  2015cites this paper
• Cardiovascular risk found in Cushing syndrome

  2014cites this paper
• Endocrine evaluation of erectile dysfunction

  2014cites this paper
• Changes in stress hormones and metabolism during a 105-day simulated Mars mission.

  2014cites this paper
• Cushing’s syndrome in type 2 diabetes patients with poor glycemic control

  2014cites this paper
• Pathophysiology and treatment of subclinical Cushing's disease and pituitary silent corticotroph adenomas [Review].

  2014cites this paper
• Ambulatory blood pressure monitoring-derived short-term blood pressure variability is increased in Cushing’s syndrome

  2014cites this paper
• Subclinical Cushing’s syndrome: Current concepts and trends

  2014cites this paper
• Mifepristone: is there a place in the treatment of Cushing’s disease?

  2013cites this paper
• Efeito do glucagon sobre a contração da musculatura lisa das vias aéreas de camundongos A/J

  2013cites this paper
• An accurate, non-invasive approach to diagnose Cushing's syndrome in at-risk populations.

  2013cites this paper
• The Yin Yang of Hormones that Control Glucose Homeostasis in Asthma

  2013cites this paper
• Investigational anti-hyperglycemic agents: the future of type 2 diabetes therapy?

  2013cites this paper
• Significantly high level of late‐night free cortisol to creatinine ratio in urine specimen in patients with subclinical Cushing's syndrome

  2013cites this paper
• Glucocorticoids and the regulation of growth hormone secretion

  2013cites this paper
• Epicardial fat thickness and left ventricular mass in subjects with adrenal incidentaloma

  2013cites this paper
• Glucocorticoids and Type 2 Diabetes: From Physiology to Pathology

  2012cites this paper